Search Results

There are 20659 results for: content related to: Imatinib-induced gastric antral vascular ectasia in a patient with chronic myeloid leukemia

  1. You have free access to this content
    Potent mechanism-based inhibition of CYP3A4 by imatinib explains its liability to interact with CYP3A4 substrates

    British Journal of Pharmacology

    Volume 165, Issue 8, April 2012, Pages: 2787–2798, AM Filppula, J Laitila, PJ Neuvonen and JT Backman

    Article first published online : 23 MAR 2012, DOI: 10.1111/j.1476-5381.2011.01732.x

  2. You have free access to this content
    Measuring response to BCR-ABL inhibitors in chronic myeloid leukemia

    Cancer

    Volume 118, Issue 2, 15 January 2012, Pages: 300–311, Jerald P. Radich

    Article first published online : 29 JUN 2011, DOI: 10.1002/cncr.26280

  3. Human Hepatocyte Assessment of Imatinib Drug-Drug Interactions – Complexities in Clinical Translation

    British Journal of Clinical Pharmacology

    Accepted manuscript online: 15 JUL 2015, Jan H. Beumer, Venkateswaran C. Pillai, Robert A. Parise, Susan M. Christner, Brian F. Kiesel, Michelle A. Rudek and Raman Venkataramanan

    DOI: 10.1111/bcp.12723

  4. Pharmacokinetic Impact of SLCO1A2 Polymorphisms on Imatinib Disposition in Patients With Chronic Myeloid Leukemia

    Clinical Pharmacology & Therapeutics

    Volume 90, Issue 1, July 2011, Pages: 157–163, Y Yamakawa, A Hamada, T Shuto, M Yuki, T Uchida, H Kai, T Kawaguchi and H Saito

    Article first published online : 1 JUN 2011, DOI: 10.1038/clpt.2011.102

  5. Enzyme- and Transporter-Mediated Drug Interactions with Small Molecule Tyrosine Kinase Inhibitors

    Journal of Pharmaceutical Sciences

    Volume 103, Issue 12, December 2014, Pages: 3810–3833, Jie Shao, John S. Markowitz, Di Bei and Guohua An

    Article first published online : 10 OCT 2014, DOI: 10.1002/jps.24113

  6. You have free access to this content
    Controversies in the management of gastrointestinal stromal tumors

    Asia-Pacific Journal of Clinical Oncology

    Volume 10, Issue 3, September 2014, Pages: 216–227, Desmond Yip, John Zalcberg, Stephen Ackland, Andrew P Barbour, Jayesh Desai, Stephen Fox, Dusan Kotasek, Grant McArthur and B Mark Smithers

    Article first published online : 27 MAR 2014, DOI: 10.1111/ajco.12187

  7. You have free access to this content
    Practical management of patients with chronic myeloid leukemia

    Cancer

    Volume 117, Issue 19, 1 October 2011, Pages: 4343–4354, Francisco Cervantes and Michael Mauro

    Article first published online : 16 MAR 2011, DOI: 10.1002/cncr.26062

  8. Imatinib Mesylate, the First Molecularly Targeted Gene Suppressor

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 22, Issue 10, October 2002, Pages: 1249–1265, Vanita K. Pindolia and Barbara J. Zarowitz

    Article first published online : 17 JAN 2012, DOI: 10.1592/phco.22.15.1249.33482

  9. You have free access to this content
    Modulation of Imatinib Cytotoxicity by Selenite in HCT116 Colorectal Cancer Cells

    Basic & Clinical Pharmacology & Toxicology

    Volume 116, Issue 1, January 2015, Pages: 37–46, Amal Kamal Abdel-Aziz, Samar Saad Eldeen Azab, Samar Samir Youssef, Abeer Mostafa El-Sayed, Ebtehal El-Demerdash and Samia Shouman

    Article first published online : 25 JUL 2014, DOI: 10.1111/bcpt.12281

  10. You have full text access to this OnlineOpen article
    Bosutinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukaemia: results from the 24-month follow-up of the BELA trial

    British Journal of Haematology

    Volume 168, Issue 1, January 2015, Pages: 69–81, Tim H. Brümmendorf, Jorge E. Cortes, Cármino Antonio de Souza, Francois Guilhot, Ladan Duvillié, Dmitri Pavlov, Karïn Gogat, Athena M. Countouriotis and Carlo Gambacorti-Passerini

    Article first published online : 8 SEP 2014, DOI: 10.1111/bjh.13108

  11. Current and Future Clinical Strategies in the Management of Chronic Myeloid Leukemia

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 30, Issue 9P2, September 2010, Pages: 77S–101S, Kamakshi V. Rao, Andrea Iannucci and Elias Jabbour

    Article first published online : 6 JAN 2012, DOI: 10.1592/phco.30.pt2.77S

  12. Therapy of Advanced-Stage and Resistant Chronic Myeloid Leukemia

    Leukemias: Principles and Practice of Therapy

    Devendra K. Hiwase, Timothy P. Hughes, Pages: 281–295, 2011

    Published Online : 4 JAN 2011, DOI: 10.1002/9781444327359.ch23

  13. You have free access to this content
    Dose optimization of tyrosine kinase inhibitors to improve outcomes in GIST

    Asia-Pacific Journal of Clinical Oncology

    Volume 8, Issue 1, March 2012, Pages: 43–52, John R. ZALCBERG and Jayesh DESAI

    Article first published online : 20 FEB 2012, DOI: 10.1111/j.1743-7563.2011.01491.x

  14. Pharmacokinetic interactions among imatinib, bosentan and sildenafil, and their clinical implications in severe pulmonary arterial hypertension

    British Journal of Clinical Pharmacology

    Volume 80, Issue 1, July 2015, Pages: 75–85, Didier Renard, Thomas Bouillon, Ping Zhou, Gerard Flesch and Debbie Quinn

    Article first published online : 1 JUN 2015, DOI: 10.1111/bcp.12584

  15. Adiponectin enhances Imatinib anti-tumour activity in human chronic myeloid leukaemia cells with serum levels associated with Imatinib efficacy in early chronic phase patients

    Cell Proliferation

    Volume 48, Issue 4, August 2015, Pages: 486–496, Guangshan Tan, Lei Shi, Qiang Li and Mingjun Wang

    Article first published online : 6 JUL 2015, DOI: 10.1111/cpr.12194

  16. You have free access to this content
    Valproate enhances imatinib-induced growth arrest and apoptosis in chronic myeloid leukemia cells

    Cancer

    Volume 106, Issue 5, 1 March 2006, Pages: 1188–1196, Alessandro Morotti, Daniela Cilloni, Francesca Messa, Francesca Arruga, Ilaria Defilippi, Sonia Carturan, Renata Catalano, Valentina Rosso, Annalisa Chiarenza, Chiara Pilatrino, Angelo Guerrasio, Riccardo Taulli, Enrico Bracco, Marisa Pautasso, Daniela Baraban, Enrico Gottardi and Giuseppe Saglio

    Article first published online : 27 JAN 2006, DOI: 10.1002/cncr.21725

  17. You have free access to this content
    Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis

    Arthritis & Rheumatism

    Volume 56, Issue 1, January 2007, Pages: 311–322, Jörg H. W. Distler, Astrid Jüngel, Lars C. Huber, Ursula Schulze-Horsel, Jochen Zwerina, Renate E. Gay, Beat A. Michel, Thomas Hauser, Georg Schett, Steffen Gay and Oliver Distler

    Article first published online : 28 DEC 2006, DOI: 10.1002/art.22314

  18. You have free access to this content
    Perspective on updated treatment guidelines for patients with gastrointestinal stromal tumors

    Cancer

    Volume 116, Issue 22, 15 November 2010, Pages: 5126–5137, Jean-Yves Blay, Margaret von Mehren and Martin E. Blackstein

    Article first published online : 3 NOV 2010, DOI: 10.1002/cncr.25267

  19. You have free access to this content
    Optimizing therapy for patients with chronic myelogenous leukemia in chronic phase

    Cancer

    Volume 116, Issue 6, 15 March 2010, Pages: 1419–1430, Hagop M. Kantarjian, Jorge Cortes, Paul La Rosée and Andreas Hochhaus

    Article first published online : 29 JAN 2010, DOI: 10.1002/cncr.24928

  20. You have free access to this content
    First-line therapy for chronic myeloid leukemia: Past, present, and future

    American Journal of Hematology

    Volume 84, Issue 5, May 2009, Pages: 287–293, Carolina Pavlovsky, Hagop Kantarjian and Jorge E. Cortes

    Article first published online : 19 FEB 2009, DOI: 10.1002/ajh.21380